News
News
Academy
Multimedia
Editorial PodcastsEditorial VideosPeer ExchangeProfiles in Medicine
Conferences
Conference CoverageConference Listing
More
Publications
Pharmaceutical Executive
Partner Perspectives
Resources
Content Engagement HubsE-BooksEventsSponsored PodcastsSponsored VideosWebcastsWhitepapers

Subscribe

  • News
  • Academy
  • Multimedia
  • Conferences
  • Publications
  • Partner Perspectives
  • Resources
  • Subscribe
  • Corporate Communications
    • Press Releases
    • Executive Roundtable
    • Executive Profiles
    • Leadership
  • Direct-to-Consumer
    • Patient Education
    • Healthcare Access
    • Telehealth
  • Emerging Biopharma
    • Partnerships
    • Funding
  • IR Licensing and Partnerships
    • Finance
    • Industry Trends
  • Market Access
    • Patient Access
    • Pricing
    • Strategy
  • Medical Affairs
    • Patient Advocacy
    • Clinical Data
    • Pharmacovigilance
  • Operations
    • Sustainability
    • Technology
    • R&D/Clinical Trials
    • Supply Chain
  • Patient Engagement
    • DE&I
  • Regulatory
    • FDA
    • Legal
    • Global
  • Sales & Marketing
    • Sales Effectiveness
    • Campaigns
    • DTC Marketing
    • Medical Education
Spotlight -
Asembia 2025 |
Sales Effectiveness|
Latest Executive Roundtables
Advertisement
|Articles|October 13, 2015

OmniComm Infographic eSource Easier Than You Think

Advertisement
External Link - Advanstar ACT Omni eSource[jess]10-6-15.pdf

Newsletter

Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

Subscribe Now!
Advertisement

Related Content

Advertisement
Image courtesy of Eli Lilly and Company

Lilly Announces Partnership with Walmart Pharmacy Launching First Retail Pick-Up Option Offering Direct-To-Consumer Priced Zepbound

ByNicholas Jacobus
October 29th 2025
Chris O'Dell

What Impact will DTC Programs have on Generic Drug Prices?

ByMike Hollan,Chris O'Dell
October 29th 2025
Marcel Botha

What Impact will FDA's ANDA Prioritization Pilot have on the Global Supply Chain?

ByMike Hollan,Marcel Botha
October 29th 2025
Pharmaceutical Executive

Pharmaceutical Executive Daily: Organon CEO Kevin Ali Resigns

ByNicholas Jacobus
October 28th 2025
Stock.adobe.com

GSK Enters $745 Million Worldwide Exclusive License Agreement with Empirico for Clinical-Stage First-In-Class Oligonucleotide Candidate

ByNicholas Jacobus
October 28th 2025
Advertisement
Advertisement

Trending on PharmExec

1

FDA Approves Single-Injection, Once-Monthly Maintenance Regimen for Lilly’s Omvoh in Ulcerative Colitis

2

Pharmaceutical Executive Daily: Organon CEO Kevin Ali Resigns

3

GSK Enters $745 Million Worldwide Exclusive License Agreement with Empirico for Clinical-Stage First-In-Class Oligonucleotide Candidate

4

FDA Expands Indication for Merck’s Winrevair in Pulmonary Arterial Hypertension

5

What Impact will DTC Programs have on Generic Drug Prices?

  • About
  • Advertise
  • Contact Us
  • Editorial Board
  • Editorial Submission Guidelines
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us